Skip to main content
    C

    Calumet Specialty Products Partners (CLMT)

    Official site

    BASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ

    $31.82
    -0.14 (-0.44%)

    Market Cap: $3.02B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Calumet Specialty Products Partners (CLMT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Calumet Specialty Products Partners (CLMT) has a market cap of $3.02B and an enterprise value of $4.97B. Revenue grew 28.37% over the last 12 months from the 12 months before. Its net debt of $1.95B equals 64.43% of its market cap.

    Total Valuation

    Enterprise value is 64.43% above the market cap, as debt exceeds cash.

    Market Cap$3.02B
    Enterprise Value$4.97B
    Latest price (Nov 17, 2026)$31.82

    Key Dates

    The next earnings report is expected on Feb 25, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 25, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.50% in the quarter ended Sep 30, 2026 and grew 1.45% a year over 2 years.

    Shares Outstanding88.02M
    Shares Change (YoY)+1.51%
    Shares Change (QoQ)+0.50%
    Share Count Growth (2Y CAGR)+1.45%

    Valuation Ratios

    The price to sales ratio is 0.5x.

    P/E Ratio8.4x
    P/S Ratio0.5x
    Forward P/S0.6x
    P/FCF Ratio10.6x
    P/OCF Ratio8.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 17.9x free cash flow.

    EV / Sales1.0x
    EV / FCF17.9x

    Price Statistics

    The stock is up 70.43% over 52 weeks and trades 37.60% below its 50-day average.

    Beta (1Y)-0.17
    52-Week Change+70.43%
    1-Month Change-42.71%
    3-Month Change-35.31%
    6-Month Change-1.27%
    Total Return (1Y)+70.43%
    Return vs SPY (1Y)+55.21%
    Max Drawdown (1Y)-46.11%
    Max Drawdown (3Y)-61.87%
    Sharpe Ratio (1Y)1.08
    Correlation with SPY (1Y)-0.05
    50-Day Average$50.99
    200-Day Average$39.56
    52-Week Range$17.85 to $59.87
    RSI (14 Days)20.4
    Average Volume (20 Days)1.69M

    Price chart

    Financial Position

    Current assets cover 1.06x current liabilities.

    Current Ratio1.06x
    Quick Ratio0.66x
    Debt / EBITDA7.94x
    Debt / FCF8.19x
    Interest Coverage-0.19x

    Returns and Efficiency

    Return on invested capital is -9.80% over the last 12 months, against a 5-year average of 2.33%.

    Return on Assets (ROA)-6.47%
    Return on Invested Capital (ROIC)-9.80%
    Return on Capital Employed (ROCE)-10.74%
    ROA (5Y Average)-5.15%
    ROIC (5Y Average)2.33%
    Asset Turnover1.81x
    Inventory Turnover10.57x
    Receivables Turnover11.77x
    Cash Conversion Cycle35 days

    Scores

    CLMT has an Altman Z-Score of 1.21, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score1.21
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $5.20B over the last 12 months.

    Revenue$5.20B
    Revenue Growth (YoY)+28.37%
    Gross Profit$471.00M
    Operating Income$179.20M
    Pretax Income-$298.70M
    Net Income-$193.80M
    EBIT-$196.20M
    Reported EPS (TTM)$3.78

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$225.20M
    Total Debt$2.17B
    Net Debt$1.95B
    Net Debt Per Share$22.12
    Working Capital$73.90M
    Shareholder Equity-$870.70M
    Total Assets$2.99B
    Total Liabilities$3.60B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $76.00M of capital spending, operating cash flow left $265.10M of free cash flow.

    Operating Cash Flow$341.10M
    Capital Expenditures$76.00M
    Free Cash Flow$265.10M
    FCF Per Share$3.01
    Depreciation and Amortization$148.80M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 3.45%, against a 5-year average of 1.60%.

    Gross Margin9.06%
    Operating Margin3.45%
    Pretax Margin-5.75%
    Net Margin-3.73%
    EBIT Margin-3.78%
    FCF Margin5.10%
    Gross Margin (5Y Average)6.86%
    Operating Margin (5Y Average)1.60%
    Net Margin (5Y Average)-3.34%

    Growth

    Revenue fell 4.07% a year over 3 years.

    Revenue Growth (3Y CAGR)-4.07%
    Revenue Growth (5Y CAGR)+12.77%
    FCF Growth (5Y CAGR)+24.66%
    Operating Income Growth (3Y CAGR)-25.66%

    Revenue and profit by year

    Dividends and Yields

    CLMT does not pay a dividend. Its free cash flow yield is 9.46%.

    Earnings Yield11.90%
    FCF Yield9.46%
    Shareholder Yield0.00%

    Peer Position

    Against 12 similar companies, CLMT has the lowest P/E and the 12th highest P/S.

    P/E Ratio8.4x vs 20.0x median
    P/S Ratio0.5x vs 1.6x median
    ROIC-9.80% vs 7.45% median
    Revenue Growth (Trailing 4 Quarters, YoY)+28.37% vs +8.40% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 9.43% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+9.43%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLMT

    What is CLMT's market cap?

    Calumet Specialty Products Partners has a market cap of $3.02B. Its enterprise value, which adds debt and subtracts cash, is $4.97B.

    What is CLMT's P/E ratio?

    Calumet Specialty Products Partners has a trailing P/E ratio of 8.4x.

    How many shares of CLMT are outstanding?

    Calumet Specialty Products Partners has 88.02M shares outstanding. The count is up 1.51% from a year earlier.

    Does CLMT pay a dividend?

    No. Calumet Specialty Products Partners does not pay a dividend.

    How much debt does CLMT have?

    Calumet Specialty Products Partners has $2.17B of total debt and $225.20M of cash and equivalents, a net debt position of $1.95B.